|Increased oxidative stress and hypozincemia in male obesity|
M Ozata, M Mergen, C Oktenli, A Aydin, SY Sanisoglu, E Bolu, MI Yilmaz, ...
Clinical biochemistry 35 (8), 627-631, 2002
|The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine|
MI Yilmaz, M Saglam, K Caglar, E Cakir, A Sonmez, T Ozgurtas, A Aydin, ...
American Journal of Kidney Diseases 47 (1), 42-50, 2006
|Prostate cancer and adiponectin|
S Goktas, MI Yilmaz, K Caglar, A Sonmez, S Kilic, S Bedir
Urology 65 (6), 1168-1172, 2005
|Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance|
T Dogru, A Sonmez, I Tasci, E Bozoglu, MI Yilmaz, H Genc, G Erdem, ...
Diabetes research and clinical practice 76 (1), 24-29, 2007
|Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients|
T Celik, A Iyisoy, H Kursaklioglu, E Kardesoglu, S Kilic, H Turhan, ...
Journal of hypertension 24 (3), 591-596, 2006
|Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma|
AL Gomes, A Teijeiro, S Burén, KS Tummala, M Yilmaz, A Waisman, ...
Cancer cell 30 (1), 161-175, 2016
|Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease|
M Kanbay, Y Solak, HU Unal, YG Kurt, M Gok, H Cetinkaya, M Karaman, ...
International urology and nephrology 46, 1619-1625, 2014
|Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease|
JJ Carrero, AR Qureshi, J Axelsson, MI Yilmaz, S Rehnmark, MR Witt, ...
Journal of internal medicine 262 (6), 690-701, 2007
|FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease|
MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, E Demirkaya, ...
Kidney international 78 (7), 679-685, 2010
|Leptin influences cellular differentiation and progression in prostate cancer|
K Saglam, E Aydur, MI Yilmaz, S Goktas
Journal of Urology 169 (4), 1308-1311, 2003
|Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin|
MI Yilmaz, M Saglam, AR Qureshi, JJ Carrero, K Caglar, T Eyileten, ...
Nephrology Dialysis Transplantation 23 (5), 1621-1627, 2008
|Serum visfatin concentration and endothelial dysfunction in chronic kidney disease|
MI Yilmaz, M Saglam, JJ Carrero, AR Qureshi, K Caglar, T Eyileten, ...
Nephrology Dialysis Transplantation 23 (3), 959-965, 2008
|Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial|
MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, T Eyileten, K Caglar, ...
American journal of kidney diseases 59 (2), 177-185, 2012
|Inhibition of de novo NAD+ synthesis by oncogenic URI causes liver tumorigenesis through DNA damage|
KS Tummala, AL Gomes, M Yilmaz, O Graña, L Bakiri, I Ruppen, ...
Cancer cell 26 (6), 826-839, 2014
|Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients|
Y Baykal, K Saglam, MI Yilmaz, A Taslipinar, SB Akinci, A Inal
Clinical rheumatology 22, 99-101, 2003
|Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease|
ME Suliman, MI Yilmaz, JJ Carrero, AR Qureshi, M Saglam, OM Ipcioglu, ...
Clinical Journal of the American Society of Nephrology 3 (4), 976-985, 2008
|Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease|
MI Yilmaz, D Siriopol, M Saglam, YG Kurt, HU Unal, T Eyileten, M Gok, ...
Kidney international 86 (6), 1213-1220, 2014
|Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients|
M Kanbay, MI Yilmaz, M Apetrii, M Saglam, H Yaman, HU Unal, M Gok, ...
American journal of nephrology 36 (3), 228-237, 2012
|Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients|
K Caglar, MI Yilmaz, M Saglam, E Cakir, C Acikel, T Eyileten, M Yenicesu, ...
Clinical Journal of the American Society of Nephrology 3 (1), 61-68, 2008
|Cytokine dysregulation in chronic kidney disease: how can we treat it?|
JJ Carrero, MI Yilmaz, B Lindholm, P Stenvinkel
Blood purification 26 (3), 291-299, 2008